Boryung Corporation (KRX:003850)
8,650.00
0.00 (0.00%)
At close: Jun 5, 2025, 3:30 PM KST
Boryung Revenue
Boryung had revenue of 240.55B KRW in the quarter ending March 31, 2025, with 2.97% growth. This brings the company's revenue in the last twelve months to 1.02T, up 15.14% year-over-year. In the year 2024, Boryung had annual revenue of 1.02T with 18.32% growth.
Revenue (ttm)
1,024.06B
Revenue Growth
+15.14%
P/S Ratio
0.71
Revenue / Employee
668.01M
Employees
1,533
Market Cap
726.28B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1,017.11B | 157.48B | 18.32% |
Dec 31, 2023 | 859.63B | 99.15B | 13.04% |
Dec 31, 2022 | 760.48B | 133.20B | 21.23% |
Dec 31, 2021 | 627.28B | 65.41B | 11.64% |
Dec 31, 2020 | 561.87B | 37.60B | 7.17% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2012 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,898.69B |
Celltrion | 3,662.23B |
ALTEOGEN | 151.65B |
Yuhan | 2,114.76B |
SK Biopharmaceuticals | 578.00B |
HLB Co., Ltd. | 74.64B |
PharmaResearch | 392.31B |
LigaChem Biosciences | 146.42B |